Abstract
Rights: UNKNOWN · https://www.elsevier.com/tdm/userlicense/1.0/ · Source: journal-auto-sync:external:CROSSREF_ISSN
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
W Parulekar, R Mackenzie, G Bjarnason, R.C.K Jordan
Abstract
Rights: UNKNOWN · https://www.elsevier.com/tdm/userlicense/1.0/ · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer
10.1016/0360-3016(90)90342-h · 1990
Placebo controlled randomized trial of infusion fluorouracil during standard radiotherapy in locally advanced head and neck cancer
10.1200/jco.1994.12.12.2648 · 1994
Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer
10.1200/jco.1987.5.9.1410 · 1987
Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer
10.1016/0360-3016(89)90362-3 · 1989
Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: preliminary report of a randomized trial
10.1016/0360-3016(91)90098-o · 1991
Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck: the final report of a randomized trial
10.1002/1097-0142(19910215)67:4<915::aid-cncr2820670410>3.0.co;2-8 · 1991
Treatment of advanced squamous cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy
10.1056/nejm199210153271602 · 1992
A randomized trial of neoadjuvant vs. concomitant chemotherapy vs. radiotherapy alone in the treatment of stage IV head and neck squamous cell carcinoma
10.1007/bf00178472 · 1992
Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: results from two randomized clinical trials
10.1016/0360-3016(93)90234-m · 1993
Radiotherapy combined with simultaneous chemotherapy with mitomycin, and bleomycin for inoperable head and neck cancer—preliminary report
10.1016/0360-3016(95)00525-4 · 1995
Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer
10.1200/jco.1994.12.2.385 · 1994
Concomitant boost technique using accelerated superfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck
10.1002/1097-0142(19920601)69:11<2749::aid-cncr2820691120>3.0.co;2-4 · 1992
Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma
10.1016/0360-3016(91)90670-y · 1991
Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy
10.1016/0167-8140(92)90242-m · 1992
Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity
10.1016/0167-8140(96)01776-8 · 1996
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
X-ray sensitivity and DNA synthesis in synchronous populations of HeLa cells
10.1126/science.140.3566.490 · 1963
X-ray sensitivity during cell generation cycle of cultured Chinese hamster cells
10.2307/3572025 · 1966
Differing responses to radiation of murine bone marrow stem cells in relation to the cell cycle
1971
Age response to X-rays, vinca alkaloids and hydroxyurea of murine lymphoma cells synchronized in vivo
1970
Dental management of the cancer patient receiving radiation therapy
1980
Unresolved referenced work
Kept as external metadata until matched
Smoking and mucosal reactions to radiotherapy
10.1259/0007-1285-63-751-554 · 1990
Consequences of breast irradiation in patients with pre-existing collagen vascular diseases
10.1016/0360-3016(89)90074-6 · 1989
Nasopharyngeal carcinoma with dermatomyositis
10.1016/0360-3016(89)90344-1 · 1989
Fatal outcome of pelvic radiotherapy for carcinoma of the cervix in a patient with systemic lupus erythematosis
10.1016/s0009-9260(89)80040-6 · 1989
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Clinicothologic effects of cancer chemotherapeutic agents on human buccal mucosa
10.1016/0030-4220(77)90244-4 · 1977
Prevention and management of oral mucositis induced by antineoplastic therapy
1991
Oral complications of cancer chemotherapy in pediatric patients
1979
Quantitative analysis of the oral complications of antileukemic chemotherapy
10.1016/0030-4220(86)90258-6 · 1986
The role of herpes simplex virus in the development of oral mucositis in bone marrow transplant recipients
10.1002/1097-0142(19901201)66:11<2375::aid-cncr2820661121>3.0.co;2-6 · 1990
Periodontal infection in patients with acute nonlmphocytic leukemia: prevalence of acute exacerbations
10.1001/archinte.142.3.551 · 1982
Intestinal adaptation (first of two parts): structural, functional and cytokinetic changes
10.1056/nejm197806222982505 · doi-reference
The reduction of radiation mucositis by selective decontamination antibiotic pastilles: a placebo-controlled double-blind trial
10.1038/bjc.1996.359 · doi-reference
Studies of oral neutrophil levels in patients receiving G-CSF after autologous marrow transplantation
10.1111/j.1365-2141.1992.tb06472.x · doi-reference
Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation
10.1016/s0140-6736(89)91552-3 · doi-reference
Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis after hematopoietic stem-cell transplantation
10.1200/jco.1994.12.9.1917 · doi-reference
Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium
10.1056/nejm198806023182202 · doi-reference
Transforming growth factor-β3 mediated modulation of cell cycling and attenuation of 5-fluorouracil induced oral mucositis
10.1016/s0964-1955(96)00043-7 · doi-reference
Prophylaxis of oral mucositis associated with chemoradiotherapy or oral carcinoma by azelastine hydrochloride (Azelastine) with other antioxidants
10.1002/hed.2880160407 · doi-reference
Vitamin E in the treatment of chemotherapy-induced mucositis
10.1016/0002-9343(92)90744-v · doi-reference
The modifying effect of beta-carotene on radiation and chemotherapy induced oral mucositis
10.1038/bjc.1988.94 · doi-reference
Comparative evaluation of benzydamine oral rinse, in children with antineoplastic-induced stomatitis
10.1177/106002808702100412 · doi-reference
Prevention of oral mucositis in radiation therapy: a controlled study with benzydamine hydrochloride rinse
10.1016/0360-3016(89)90964-4 · doi-reference
Prostaglandin inhibitor and radiotherapy in advanced head and neck cancers
10.1001/archotol.1986.03780050076013 · doi-reference
Benzydamine hydrochloride in prevention and management of pain in oral mucositis associated with radiation therapy
10.1016/0030-4220(86)90035-6 · doi-reference
Local benefit of prosplandin E2 in radiochemotherapy-induced oral mucositis
10.1016/0266-4356(90)90128-8 · doi-reference
Local prostaglandin E2 in patients with oral malignancies undergoing chemo- and radiotherapy
10.1016/s1010-5182(88)80082-9 · doi-reference
Topical PGE2 enhances healing of chemotherapy-associated mucosal lesions (letter)
10.1016/s0140-6736(86)92850-3 · doi-reference
The efficacy of sucralfate suspension in the prevention of oral mucositis due to radiation therapy
10.1016/0360-3016(94)90195-3 · doi-reference
The effects of sucralfate suspension and diphenhydramine syrup plus kaolin-pectin on radiotherapy-induced mucositis
10.1016/0030-4220(91)90301-r · doi-reference
A prospective pilot study on the effect of sucralfate mouth-swishing in reducing stomatitis during radiotherapy of the oral cavity
10.3109/02841869009090032 · doi-reference
Effect of prophylactic sucralfate suspension on stomatitis induced by cancer chemotherapy: a randomized, double-blind cross-over study
10.3109/02841869009126540 · doi-reference
Efficacy of oral sucralfate suspension in prevention and treatment of chemotherapy-induced mucositis
10.1016/s0022-3476(88)80397-4 · doi-reference
Oral sucralfate suspension for mucositis
10.1056/nejm198608143150717 · doi-reference
Sucralfate suspension for mouth ulcers (letter)
10.1177/106002808501900617 · doi-reference
Sucralfate suspension for stomatitis (letter)
10.1177/106002808401800214 · doi-reference
Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis
10.1200/jco.1994.12.12.2630 · doi-reference
Efficacy of chlorhexidene and nystatin rinses in prevention of oral complications in leukemia and bone marrow transplantation
10.1016/0030-4220(92)90009-f · doi-reference
Chlorhexidene prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomized double-blind trial
10.1016/0030-4220(90)90295-4 · doi-reference
Effects of chlorhexidene mouthrinse on oral health in patients with acute leukemia
10.1016/0030-4220(89)90212-0 · doi-reference
Effect of chlorhexidine rinsing on the oropharyngeal ecology in patients with head and neck cancer who have irradiation mucositis
10.1016/0030-4220(89)90321-6 · doi-reference
The head and neck radiotherapy questionnaire: a morbidity/quality-of-life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer
10.1200/jco.1993.11.5.863 · doi-reference
Impact of a systematic oral care protocol on stomatitis after chemotherapy
10.1097/00002820-197906000-00002 · doi-reference
10.1097/00002820-199102000-00002
10.1097/00002820-199102000-00002 · doi-reference
Quantitative scale of oral mucositis associated with autologous bone marrow transplantation
10.1016/s0964-1955(96)00026-7 · doi-reference
The recording of morbidity related to radiotherapy
10.1016/0167-8140(89)90026-1 · doi-reference
Assessing the reliability of two toxicity scales: implications for interpreting toxicity data
10.1093/jnci/85.14.1138 · doi-reference
Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)
10.1016/0360-3016(95)00060-c · doi-reference
Common toxicity criteria: The National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) experience. (Abstract)
10.1016/0197-2456(92)90182-y · doi-reference
Scoring irradiation mucositis in head and neck cancer patients
10.1111/j.1600-0714.1989.tb00756.x · doi-reference
Oral mucositis in patients undergoing bone marrow transplantation
10.1016/0030-4220(85)90237-3 · doi-reference